Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 2/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18708643 | 0.74 | HTR2C (0.33) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL12083455 | 0.74 | ALDH1A1 (0.36) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL9891022 | 0.74 | ALDH1A1 (0.36) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL13875989 | 0.68 | ALDH1A1 (0.37) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL19885349 | 0.62 | KMT2A (0.52) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL11172251 | 0.61 | ALDH1A1 (0.33) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL11174211 | 0.61 | ALDH1A1 (0.33) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL6564122 | 0.59 | ACHE (0.60) | ALDH1A1ACHE | |
| SCHEMBL11169824 | 0.58 | ALDH1A1 (0.49) | MEN1ALDH1A1POLBKMT2AACHE | |
| SCHEMBL21074258 | 0.57 | ALDH1A1 (0.39) | MEN1ALDH1A1KMT2AACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170352809-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170352809-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | FARS2, ACP1, BMP4 | DPP4 3945/4885MEN1 2090/4885ALDH1A1 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.